The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2020

Filed:

Mar. 16, 2017
Applicants:

Council of Scientific & Industrial Research, New Delhi, IN;

Mayo Clinic, Rochester, MN (US);

Inventors:

Vijay Sagar Madamsetty, Telangna, IN;

Arabinda Chaudhuri, Telangna, IN;

Debabrata Mukhopadhyay, Jacksonville, FL (US);

Assignees:

COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH, New Delhi, IN;

MAYO CLINIC, Rochester, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/12 (2006.01); A61K 31/7068 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); C07K 7/06 (2006.01); A61K 9/127 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61K 31/12 (2013.01); A61K 31/7068 (2013.01); A61K 39/0011 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/6018 (2013.01);
Abstract

The present invention discloses a Plectin-1 receptor targeting novel cationic KTLLPTPK(SEQ ID NO: 1)-lipopeptide. The present invention further discloses a liposomal formulation comprising the cationic KTLLPTPK(SEQ ID NO: 1)-lipopeptide, at least two co-lipids, a therapeutic agent, and a pharmaceutically acceptable carrier. The present invention also provides a method for regressing established pancreatic tumors comprising administering a therapeutically effective amount of the liposomal formulation with the therapeutic agents in combination with targeted genetic immunization (DNA vaccination) i.e. by immunizing mice with electrostatic complexes (direct in-vivo DC-targeting cationic liposomes) of DNA vaccines encoding mesothelin (p-CMV-MSLN).


Find Patent Forward Citations

Loading…